Skip to main content
Log in

Severe infusion reaction induced by trastuzumab: A case report

  • Case Report
  • Published:
Breast Cancer Aims and scope Submit manuscript

Abstract

We report a case of a severe infusion reaction caused by trastuzumab. A 59-year-old woman with metastatic breast cancer was treated with trastuzumab. During the first infusion, initial symptoms such as severe headache and general fatigue developed. Blood pressure fell 90 minutes after these initial symptoms. A collapsed lung was demonstrated by chest X-ray and computed tomography. Steroid therapy was successfully used for these reactions. Careful monitoring of vital signs, examination of the respiratory system, and the use of steroids are recommended for severe infusion reaction.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

References

  1. Slamon DJ, Leyland-Jones B, Shak S, Fuchs H, Paton V, Bajamonde A, Fleming T, Eiermann W, Wolter J, Pegram M, Baselga J, Norton L: Use of chemotherapy plus a monoclonal antibody against HER2 for metastatic breast cancer that overexpresses HER2.N Engl J Med 344: 783–792, 2001.

    Article  PubMed  CAS  Google Scholar 

  2. Herceptin (Trastuzumab). Product Information. 1998.

  3. Dillman RO: Infusion reactions associated with the therapeutic use of monoclonal antibodies in the treatment of malignancy.Cancer Metastasis Rev 18: 465–471, 1999.

    Article  PubMed  CAS  Google Scholar 

  4. Dillman RO, Beauregard JC, Halpern SE, Clutter M: Toxicities and side effects associated with intravenous infusions of murine monoclonal antibodies.J Biol Response Mod 5: 73–84, 1986.

    PubMed  CAS  Google Scholar 

  5. Dillman RO, Beauregard JC, Jamieson M, Amox D, Halpern SE: Toxicities associated with monoclonal antibody infusions in cancer patients.Mol Biother 1: 81–85, 1988.

    PubMed  CAS  Google Scholar 

  6. Baumann H, Gauldie J: The acute phase response.Immunol Today 15: 74–80, 1994.

    Article  PubMed  CAS  Google Scholar 

  7. Munck A, Naray-Fejes-Toth A: Glucocorticoids and stress: permissive and suppressive actions.Ann N Y Acad Sci 746: 115–130, 1994.

    Article  PubMed  CAS  Google Scholar 

  8. Breuninger LM, Dempsey WL, Uhl J, Murasko DM: Hydrocortisone regulation of interleukin-6 protein production by a purified population of human peripheral blood monocytes.Clin Immunol Immunopathol 69: 205–214, 1993.

    Article  PubMed  CAS  Google Scholar 

  9. Levine SJ, Larivee P, Logun C, Angus CW, Shelhamer JH: Corticosteroids differentially regulate secretion of IL-6,IL-8, and G-CSF by a human bronchial epithelial cell line.Am J Physiol 265: 360–368, 1993.

    Google Scholar 

  10. Knudsen PJ, Dinarello CA, Strom TB: Glucocorticoids inhibit transcriptional and post-transcriptional expression of interleukin 1 in U937 cells.J Immunol 139: 4129–4134, 1987.

    PubMed  CAS  Google Scholar 

  11. Jensen M, Winker U, Manzke O, Diehl V, Engert A: Rapid tumor lysis in a patient with B-cell chronic lym-phocytic leukemia and lymphocytosis treated with an anti-CD20 monoclonal antibody (IDEC-C2B8, rituximab).Ann Hematol 77: 89–91, 1998.

    Article  PubMed  CAS  Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Keiichiro Tada.

Additional information

Reprint requests to Keiichiro Tada, Department of Medical Oncology, Cancer Institute Hospital, 1-37-1 Kami-ikebukuro, Toshima-ku, Tokyo 170-8455, Japan.

About this article

Cite this article

Tada, K., Ito, Y., Hatake, K. et al. Severe infusion reaction induced by trastuzumab: A case report. Breast Cancer 10, 167–169 (2003). https://doi.org/10.1007/BF02967644

Download citation

  • Received:

  • Accepted:

  • Issue Date:

  • DOI: https://doi.org/10.1007/BF02967644

Keywords

Navigation